← SynDRA
SB-202190
SynDRA canonical compound SYN0001011 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | MAPK14 |
| Mechanism of action | P38 MAPK inhibitor |
All known targets
- MAPK14
- AKT1
- ALOX5
- CDK8
- CHEK1
- GSK3B
- LCK
- MAPK1
- MAPK11
- MAPK12
- MAPK8
- PRKCA
Mechanisms of action (all sources)
- MAPK14 INHIBITOR
- CDK8 INHIBITOR
- PTGS2 INHIBITOR
Drug classes
Cross-references
Synonyms
- Oxindole 94
- SB202190
- FHPI
- SB202190 (FHPI)
- UNII-PVX798P8GI
- 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole
- CHEBI:79090
- 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole
- PVX798P8GI
- SB 202190, Immobilized
- C20H14FN3O
- Phenol, 4-[4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-
- 4-[4-(4-fluorophenyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl]phenol
- 4-[5-(4-fluorophenyl)-4-(pyridin-4-yl)-1H-imidazol-2-yl]phenol
- RefChem:884639
- DTXCID5021120
- MFCD00941964
- 4-[4-(4-fluorophenyl)-5-(4-pyridyl)-1H-imidazol-2-yl]phenol
- 4-[4-(4-fluorophenyl)-5-pyridin-4-yl-1H-imidazol-2-yl]phenol
- SMR001230795
- Kinome_3708
- Tocris-1264
- BiomolKI_000051
- Lopac-S-7067
- BiomolKI2_000057
- Lopac0_000173
- BMK1-F3
- BSPBio_001106
- KBioGR_000446
- KBioSS_000446
- MLS002153419
- MLS006010258
- SCHEMBL158854
- GTPL4307
- orb1305747
- SCHEMBL1230814
- SCHEMBL3386753
- BDBM13531
Look up SB-202190 in the interactive SynDRA portal →